Lowest net cost strategy helps enable provider, patient choice; helps ensure optimal, cost-effective therapy for complex inflammatory conditions.

Upcoming webinar on Nov. 6 shares more about Prime’s industry-leading ASHP-accredited PGY1 residency program

NCQA has awarded Prime Therapeutics LLC certification in Pharmacy Benefits

Prerak Parikh, PharmD, director of specialty clinical solutions at Prime Therapeutics/Magellan Rx Management, is named among 14 national 2024 Emerging Leaders in Healthcare Award recipients.